PaperScope 2.0 Summary
================================================================================

Drug: tapinarof
Disease: Plaque Psoriasis and Atopic Dermatitis
Drug Class: Small Molecule Aryl Hydrocarbon Receptor Agonist
Search Date: 2025-12-03T16:33:44.777072
Total Papers: 69
Total Searches: 21
Elapsed Time: 678.6s

Papers by Category
--------------------------------------------------------------------------------
Preclinical/Mechanistic: 7
Phase 1: 4
Phase 2: 9
Phase 3 - Primary Trials: 11
Phase 3 - Long-term Extensions: 5
Phase 3 - Pooled/Post-hoc Analyses: 7
Biomarker Studies: 1
Subgroup Analyses - Demographics: 6
Special Populations: 4
Pharmacokinetics/Pharmacodynamics: 2
Post-marketing/Real-world: 1
Safety/Pharmacovigilance: 1
Systematic Reviews/Meta-analyses: 20
Other: 4

Trial Families
--------------------------------------------------------------------------------
NCT03956355: 2 papers (Primary: 1, Extensions: 1, Post-hoc: 0, Subgroup: 0)
NCT03983980: 2 papers (Primary: 1, Extensions: 1, Post-hoc: 0, Subgroup: 0)
NRF2: 2 papers (Primary: 1, Extensions: 1, Post-hoc: 0, Subgroup: 0)
SEMA3A: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
INTERLEUKIN-17: 1 papers (Primary: 1, Extensions: 0, Post-hoc: 0, Subgroup: 0)
GSK2894512: 3 papers (Primary: 2, Extensions: 1, Post-hoc: 0, Subgroup: 0)
INTERLEUKIN-2: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
WBI-1001: 1 papers (Primary: 1, Extensions: 0, Post-hoc: 0, Subgroup: 0)
EASI-75: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
CRD420251000807: 0 papers (Primary: 0, Extensions: 0, Post-hoc: 0, Subgroup: 0)
JAK2: 0 papers (Primary: 0, Extensions: 0, Post-hoc: 0, Subgroup: 0)
STAT3: 0 papers (Primary: 0, Extensions: 0, Post-hoc: 0, Subgroup: 0)
ZBB4: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
DMVT-505: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
PASI75: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
ZBA4: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
NCT04053387: 1 papers (Primary: 0, Extensions: 1, Post-hoc: 0, Subgroup: 0)
